Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$17.63 - $21.74 $2,045 - $2,521
116 New
116 $2,000
Q1 2023

May 09, 2023

SELL
$10.7 - $15.79 $1,423 - $2,100
-133 Reduced 80.61%
32 $0
Q4 2022

Feb 13, 2023

SELL
$11.42 - $17.05 $9,524 - $14,219
-834 Reduced 83.48%
165 $2,000
Q3 2022

Oct 27, 2022

BUY
$9.76 - $13.41 $9,750 - $13,396
999 New
999 $13,000
Q2 2022

Aug 01, 2022

SELL
$7.6 - $11.41 $4,636 - $6,960
-610 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$9.3 - $12.37 $5,673 - $7,545
610 New
610 $6,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $680M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.